These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20538153)

  • 21. The use of genes for performance enhancement: doping or therapy?
    Oliveira RS; Collares TF; Smith KR; Collares TV; Seixas FK
    Braz J Med Biol Res; 2011 Dec; 44(12):1194-201. PubMed ID: 22030863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and long-term detection of gene doping in conventional blood samples.
    Beiter T; Zimmermann M; Fragasso A; Hudemann J; Niess AM; Bitzer M; Lauer UM; Simon P
    Gene Ther; 2011 Mar; 18(3):225-31. PubMed ID: 20811468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone.
    Bidlingmaier M; Strasburger CJ
    Handb Exp Pharmacol; 2010; (195):187-200. PubMed ID: 20020365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity-based biosensors as promising tools for gene doping detection.
    Minunni M; Scarano S; Mascini M
    Trends Biotechnol; 2008 May; 26(5):236-43. PubMed ID: 18367276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Growth hormone and IGF-1 as doping agents in competitive sport].
    Jóźków P; Medraś M
    Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor I and insulin and their abuse in sport.
    Erotokritou-Mulligan I; Holt RI
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):33-43, viii. PubMed ID: 20122448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone administration: is it safe and effective for athletic performance.
    Birzniece V; Nelson AE; Ho KK
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):11-23, vii. PubMed ID: 20122446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytes.
    Fernández-Cancio M; Audi L; Carrascosa A; Toran N; Andaluz P; Esteban C; Granada ML
    Growth Horm IGF Res; 2009 Jun; 19(3):232-7. PubMed ID: 19056306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair.
    Mason JM; Grande DA; Barcia M; Grant R; Pergolizzi RG; Breitbart AS
    Gene Ther; 1998 Aug; 5(8):1098-104. PubMed ID: 10326033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1.
    Smith P; Shuler FD; Georgescu HI; Ghivizzani SC; Johnstone B; Niyibizi C; Robbins PD; Evans CH
    Arthritis Rheum; 2000 May; 43(5):1156-64. PubMed ID: 10817570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometry-based analysis of IGF-1 and hGH.
    Thevis M; Bredehöft M; Kohler M; Schänzer W
    Handb Exp Pharmacol; 2010; (195):201-7. PubMed ID: 20020366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GH & IGF Research issue on doping with growth hormone.
    Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):283-4. PubMed ID: 19535276
    [No Abstract]   [Full Text] [Related]  

  • 34. Sports doping in the adolescent: the Faustian conundrum of Hors de Combat.
    Greydanus DE; Patel DR
    Pediatr Clin North Am; 2010 Jun; 57(3):729-50. PubMed ID: 20538154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
    Rogol AD
    Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence on ergogenic action of glucocorticoids as a doping agent risk.
    Duclos M
    Phys Sportsmed; 2010 Oct; 38(3):121-7. PubMed ID: 20959705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technology insight: detecting growth hormone abuse in athletes.
    Bidlingmaier M; Strasburger CJ
    Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):769-77. PubMed ID: 17955018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mighty mice: inspiration for rogue athletes?
    Vogel G
    Science; 2004 Jul; 305(5684):633. PubMed ID: 15286359
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene doping.
    Azzazy HM
    Handb Exp Pharmacol; 2010; (195):485-512. PubMed ID: 20020377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics and molecular biology of the GHRH-GH-IGF-I axis.
    Bernasconi S; Bergomi A; Milioli S; Tirendi A; Mastronardi G; Mariani S; Predieri B; Ferrari M; Geti M; Livio L; Rossi K; Forese S; Iughetti L
    Minerva Pediatr; 1999; 51(11-12):375-94. PubMed ID: 10768003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.